Therapeutic response of metastatic colorectal cancer harboring a KRAS missense mutation after combination chemotherapy with the EGFR inhibitor panitumumab

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint Dive into the research topics of 'Therapeutic response of metastatic colorectal cancer harboring a KRAS missense mutation after combination chemotherapy with the EGFR inhibitor panitumumab'. Together they form a unique fingerprint.

Medicine & Life Sciences